Cargando…
Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas
BACKGROUND: Multiple synchronous ground glass nodules (GGNs) are known to be malignant, however, they tend to progress slowly. Multiple synchronous lesions in the same patient which show different characteristics must be treated individually. METHODS: This was a retrospective review of 34 lung adeno...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310249/ https://www.ncbi.nlm.nih.gov/pubmed/32571419 http://dx.doi.org/10.1186/s13019-020-01196-x |
_version_ | 1783549334603694080 |
---|---|
author | Hotta, Takamasa Tsubata, Yukari Tanino, Akari Nakao, Mika Amano, Yoshihiro Hamaguchi, Megumi Hamaguchi, Shunichi Kishimoto, Koji Isobe, Takeshi |
author_facet | Hotta, Takamasa Tsubata, Yukari Tanino, Akari Nakao, Mika Amano, Yoshihiro Hamaguchi, Megumi Hamaguchi, Shunichi Kishimoto, Koji Isobe, Takeshi |
author_sort | Hotta, Takamasa |
collection | PubMed |
description | BACKGROUND: Multiple synchronous ground glass nodules (GGNs) are known to be malignant, however, they tend to progress slowly. Multiple synchronous lesions in the same patient which show different characteristics must be treated individually. METHODS: This was a retrospective review of 34 lung adenocarcinoma patients with multiple synchronous GGNs in an Asian population. One hundred twenty-seven single lung adenocarcinoma patients were included for comparison purposes. The follow-up period was 5 years for all patients. RESULTS: The 5-year overall survival (OS) patients with multiple lesions did not differ from that of the patients with single lesions to a statistically significant extent (Single: 81.8% vs. Multiple: 88.2%, P = 0.3602). Dominant tumors (DTs) with a ground glass component and consolidation were divided into three categories based on the consolidation-to-tumor ratio on radiological imaging. No significant differences were observed among the three DT categories. Twenty-four patients had unresected GGNs, while a progression of the unresected GGN occurred in 10 of these cases. The OS and disease-free survival (DFS) curves of patients with and without GGN progression did not differ to a statistically significant extent (OS: 80% vs. 92.9%, P = 0.3870; DFS: 80% vs. 100%, P = 0.0977). CONCLUSIONS: The outcomes were best predicted by the stage of the DT. After surgery patients require a careful follow-up because unresected GGNs may show progression. At the same time, the increase in residual lesions and the appearance of new GGNs were not related to OS. The management of such patients should be determined according to the DT with the worst prognosis. |
format | Online Article Text |
id | pubmed-7310249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73102492020-06-23 Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas Hotta, Takamasa Tsubata, Yukari Tanino, Akari Nakao, Mika Amano, Yoshihiro Hamaguchi, Megumi Hamaguchi, Shunichi Kishimoto, Koji Isobe, Takeshi J Cardiothorac Surg Research Article BACKGROUND: Multiple synchronous ground glass nodules (GGNs) are known to be malignant, however, they tend to progress slowly. Multiple synchronous lesions in the same patient which show different characteristics must be treated individually. METHODS: This was a retrospective review of 34 lung adenocarcinoma patients with multiple synchronous GGNs in an Asian population. One hundred twenty-seven single lung adenocarcinoma patients were included for comparison purposes. The follow-up period was 5 years for all patients. RESULTS: The 5-year overall survival (OS) patients with multiple lesions did not differ from that of the patients with single lesions to a statistically significant extent (Single: 81.8% vs. Multiple: 88.2%, P = 0.3602). Dominant tumors (DTs) with a ground glass component and consolidation were divided into three categories based on the consolidation-to-tumor ratio on radiological imaging. No significant differences were observed among the three DT categories. Twenty-four patients had unresected GGNs, while a progression of the unresected GGN occurred in 10 of these cases. The OS and disease-free survival (DFS) curves of patients with and without GGN progression did not differ to a statistically significant extent (OS: 80% vs. 92.9%, P = 0.3870; DFS: 80% vs. 100%, P = 0.0977). CONCLUSIONS: The outcomes were best predicted by the stage of the DT. After surgery patients require a careful follow-up because unresected GGNs may show progression. At the same time, the increase in residual lesions and the appearance of new GGNs were not related to OS. The management of such patients should be determined according to the DT with the worst prognosis. BioMed Central 2020-06-22 /pmc/articles/PMC7310249/ /pubmed/32571419 http://dx.doi.org/10.1186/s13019-020-01196-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Hotta, Takamasa Tsubata, Yukari Tanino, Akari Nakao, Mika Amano, Yoshihiro Hamaguchi, Megumi Hamaguchi, Shunichi Kishimoto, Koji Isobe, Takeshi Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title | Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title_full | Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title_fullStr | Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title_full_unstemmed | Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title_short | Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas |
title_sort | comparative postoperative outcomes of ggn-dominant vs single lesion lung adenocarcinomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310249/ https://www.ncbi.nlm.nih.gov/pubmed/32571419 http://dx.doi.org/10.1186/s13019-020-01196-x |
work_keys_str_mv | AT hottatakamasa comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT tsubatayukari comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT taninoakari comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT nakaomika comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT amanoyoshihiro comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT hamaguchimegumi comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT hamaguchishunichi comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT kishimotokoji comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas AT isobetakeshi comparativepostoperativeoutcomesofggndominantvssinglelesionlungadenocarcinomas |